Norman “Ned” Sharpless Oct. 17 was sworn in as the 15th NCI director, succeeding Harold Varmus, who stepped down as director in March 2015, and Douglas Lowy, who has served as acting director since that time.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
